Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors

Brunda, 1993, Antitumor and antimetastatic activity of interleukin 12 against murine tumors, J. Exp. Med., 178, 1223, 10.1084/jem.178.4.1223

Burnham, 1989, Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms, Transplantation, 47, 533, 10.1097/00007890-198903000-00027

Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, 72, 3666

Colombo, 1994, Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?, Immunol. Today, 15, 48, 10.1016/0167-5699(94)90131-7

DeVita, 1991, Biologic Therapy of Cancer, 1

Dighe, 1993, Inhibition of cellular responsiveness to interferon-γ (IFNγ) induced by overexpression of inactive forms of the IFNγ receptor, J. Biol. Chem., 268, 10645, 10.1016/S0021-9258(18)82246-3

Farrar, 1991, Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function, J. Biol. Chem., 266, 19626, 10.1016/S0021-9258(18)55039-0

Farrar, 1992, Identification of a functionally important sequence motif in the carboxy terminus of the interferon-γ receptor, 89, 11706

Fuyama, 1991, Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors, Cell. Immunol., 137, 200, 10.1016/0008-8749(91)90069-N

Gaczynska, 1993, γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes, Nature, 365, 264, 10.1038/365264a0

Green, 1984, Rapid colormetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines, J. Immunol. Meth., 70, 257, 10.1016/0022-1759(84)90190-X

Greenlund, 1994, Ligand induced IFNy receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91), EMBO, 13, 1591, 10.1002/j.1460-2075.1994.tb06422.x

Havell, 1988, The antitumor function of tumor necrosis factor (TNF), J. Exp. Med., 167, 1067, 10.1084/jem.167.3.1067

Hemmi, 1994, A novel member of the interferon receptor family complements functionality of the murine interferon-gamma receptor in human cells, Cell, 76, 803, 10.1016/0092-8674(94)90355-7

Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334, 10.1038/348334a0

LeClaire, 1992, Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-γ receptor, J. Leukocyte Biol., 51, 507, 10.1002/jlb.51.5.507

Müller, 1993, The protein tyrosine kinase JAK1 complements a mutant cell line defective in the interferon-alpha/beta and -gamma signal transduction pathways, Nature, 366, 129, 10.1038/366129a0

Nastala, 1994, Recombinant interleukin-12 administration induces tumor regression in association with interferongamma production, J. Immunol., 153, 1697, 10.4049/jimmunol.153.4.1697

North, 1988, The antitumor function of tumor necrosis factor (TNF), J. Exp. Med., 167, 1086, 10.1084/jem.167.3.1086

Old, 1985, Tumor necrosis factor (TNF), Science, 230, 630, 10.1126/science.2413547

Pardoll, 1992, New strategies for active immunotherapy with genetically engineered tumor cells, Curr. Opin. Immunol., 4, 619, 10.1016/0952-7915(92)90037-F

Rogers, 1992, Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice, 89, 1011

Schreiber, 1985, Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity, J. Immunol., 134, 1609, 10.4049/jimmunol.134.3.1609

Shuai, 1992, Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein, Science, 258, 1808, 10.1126/science.1281555

Soh, 1994, Identification and sequence of an accessory factor required for activation of the human IFNγ receptor, Cell, 76, 793, 10.1016/0092-8674(94)90354-9

Tartaglia, 1992, Tumor necrosis factor receptor signaling: a dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor, J. Biol. Chem., 267, 4304, 10.1016/S0021-9258(18)42833-5

Teng, 1991, Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell Immunity, 88, 3535

Teng, 1993, Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein, Clin. Immunol. Immunopath., 69, 215, 10.1006/clin.1993.1172

Udono, 1994, Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo, 91, 3077

Watling, 1993, Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway, Nature, 366, 166, 10.1038/366166a0